Simplot’s Generation 2 Innate adds late blight resistance

Back in December, the USDA public comment period opened up for a next-generation transgenic potato variety developed by Simplot. The previous Simplot “Generation 1 Innate” potato, which reduced browning, acrylamide, and bruising, was approved by the USDA in November last year. Now they have another potato variety with more traits – Generation 2 Innate – which takes the traits of Generation 1 and adds late blight resistance and further reduces the acrylamide-generating potential of the tubers when you fry them.

There is a lot to discuss about this new variety and its traits, however, the first public comment period for USDA regulations ended last week. I was able to obtain some more information about the traits from Erik Gonring, who manages Industry Affairs at Simplot.

Late Blight resistance is an important trait, and can significantly reduce the cost and environmental impact of the pesticides that are used to control this pathogen. While there is late blight resistance in other varieties of potato, what most people don’t realize is that due to market factors from growers to processors to consumers – these very different varieties will have a difficult time gaining acceptance. If the farmer can’t sell them, they won’t grow them. So getting this trait into an elite, modern variety is of tantamount importance.

Read full original article: Comment Today on the next Genetically Engineered Potato

 

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Jun-15-2026-11_00_13-AM-2
Glucosamine alert: Alzheimer’s progresses faster among those taking the popular supplement
Screen Shot at AM
Facts & Fallacies Podcast: Right-wing politics bad for your health? Separating speculation from science
ChatGPT-Image-Jun-9-2026-01_11_37-PM
Turmeric supplements: More risks than benefits
ChatGPT-Image-Jun-15-2026-12_13_41-PM
Viewpoint: Behind the effort to re-purpose the tobacco attack strategy to fight ultra-processed foods
ChatGPT-Image-Jun-3-2026-04_29_13-PM
Viewpoint: While unvaccinated children are dying overseas, Congress challenges Trump and Kennedy’s block on aid
Screenshot-2026-06-12-at-2.10.55-PM
Physician warns online statin myths delay care and raise heart risk
ChatGPT-Image-Jun-14-2026-09_41_44-AM-2
Viewpoint—‘The gleeful efficiency of an arsonist’: Administration’s health and science research cuts are ‘sabotaging’ America’s future
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-06-14-at-9.14.26-AM
‘Humanitarian catastrophe’: Trump’s USAID shutdown could help drive nearly 23 million deaths — including 5.4 million children — by 2030, Lancet study warns
ChatGPT-Image-Jun-11-2026-01_15_03-PM
Selective Pressure, Selective Silence
Screenshot-2026-06-05-at-2.12.30-PM
Some plants can poison you. So how did humans figure out what is safe to eat?
ChatGPT-Image-Jun-15-2026-10_42_06-AM
Viewpoint: ‘Steroid Olympics’ marketing stunt: ‘It seemed less like a sporting event and more like a loss leader to peddle testosterone injections, GLP-1s, and peptides’
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.